Drug Profile
Pelgifatamab corixetan - Bayer
Alternative Names: BAY-2315497; PSMA targeted thorium-227 conjugate; PSMA TTCLatest Information Update: 02 Jun 2023
Price :
$50
*
At a glance
- Originator Bayer
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Prostate cancer
Most Recent Events
- 14 Apr 2023 Pharmacodynamics data from a preclinical trial in prostate cancer presented at the 114th Annual Meeting of the American Association for Cancer Research (AACR-2023)
- 02 Jun 2022 3671939: updated KDM, science section and added HE
- 08 Apr 2022 Pharmacodynamics data from a preclinical study presented at the 113th Annual Meeting of the American Association for Cancer Research (AACR-2022)